251 related articles for article (PubMed ID: 20048148)
1. Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.
Vora SR; Palamakumbura AH; Mitsi M; Guo Y; Pischon N; Nugent MA; Trackman PC
J Biol Chem; 2010 Mar; 285(10):7384-93. PubMed ID: 20048148
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Palamakumbura AH; Vora SR; Nugent MA; Kirsch KH; Sonenshein GE; Trackman PC
Oncogene; 2009 Sep; 28(38):3390-400. PubMed ID: 19597471
[TBL] [Abstract][Full Text] [Related]
3. Lysyl oxidase propeptide promotes adipogenesis through inhibition of FGF-2 signaling.
Griner JD; Rogers CJ; Zhu MJ; Du M
Adipocyte; 2017 Jan; 6(1):12-19. PubMed ID: 28452589
[TBL] [Abstract][Full Text] [Related]
4. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
5. Lysyl oxidase modulates the osteoblast differentiation of primary mouse calvaria cells.
Sharma-Bhandari A; Park SH; Kim JY; Oh J; Kim Y
Int J Mol Med; 2015 Dec; 36(6):1664-70. PubMed ID: 26497171
[TBL] [Abstract][Full Text] [Related]
6. Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation.
Hurtado PA; Vora S; Sume SS; Yang D; St Hilaire C; Guo Y; Palamakumbura AH; Schreiber BM; Ravid K; Trackman PC
Biochem Biophys Res Commun; 2008 Feb; 366(1):156-61. PubMed ID: 18060869
[TBL] [Abstract][Full Text] [Related]
7. Megakaryocyte polyploidy is inhibited by lysyl oxidase propeptide.
Eliades A; Papadantonakis N; Matsuura S; Mi R; Bais MV; Trackman P; Ravid K
Cell Cycle; 2013 Apr; 12(8):1242-50. PubMed ID: 23518500
[TBL] [Abstract][Full Text] [Related]
8. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer.
Min C; Kirsch KH; Zhao Y; Jeay S; Palamakumbura AH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Feb; 67(3):1105-12. PubMed ID: 17283144
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant lysyl oxidase propeptide.
Vora SR; Guo Y; Stephens DN; Salih E; Vu ED; Kirsch KH; Sonenshein GE; Trackman PC
Biochemistry; 2010 Apr; 49(13):2962-72. PubMed ID: 20192271
[TBL] [Abstract][Full Text] [Related]
10. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation.
Mansukhani A; Ambrosetti D; Holmes G; Cornivelli L; Basilico C
J Cell Biol; 2005 Mar; 168(7):1065-76. PubMed ID: 15781477
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidase propeptide stimulates osteoblast and osteoclast differentiation and enhances PC3 and DU145 prostate cancer cell effects on bone in vivo.
Alsulaiman M; Bais MV; Trackman PC
J Cell Commun Signal; 2016 Mar; 10(1):17-31. PubMed ID: 26627907
[TBL] [Abstract][Full Text] [Related]
12. Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways.
Bais MV; Ozdener GB; Sonenshein GE; Trackman PC
Oncogene; 2015 Apr; 34(15):1928-37. PubMed ID: 24882580
[TBL] [Abstract][Full Text] [Related]
13. Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.
Wu M; Min C; Wang X; Yu Z; Kirsch KH; Trackman PC; Sonenshein GE
Cancer Res; 2007 Jul; 67(13):6278-85. PubMed ID: 17616686
[TBL] [Abstract][Full Text] [Related]
14. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
Oncol Rep; 2014 Apr; 31(4):1669-76. PubMed ID: 24573150
[TBL] [Abstract][Full Text] [Related]
15. The apoptotic and anti-proliferative effect of Lysyl oxidase propeptide in Y79 human retinoblastoma cells.
Nagaraj NR; Natarajan SK; Karunakaran C
Mol Vis; 2023; 29():125-139. PubMed ID: 38222455
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.
Pischon N; Mäki JM; Weisshaupt P; Heng N; Palamakumbura AH; N'Guessan P; Ding A; Radlanski R; Renz H; Bronckers TA; Myllyharju J; Kielbassa AM; Kleber BM; Bernimoulin JP; Trackman PC
Calcif Tissue Int; 2009 Aug; 85(2):119-26. PubMed ID: 19458888
[TBL] [Abstract][Full Text] [Related]
17. Role of lysyl oxidase propeptide in secretion and enzyme activity.
Grimsby JL; Lucero HA; Trackman PC; Ravid K; Kagan HM
J Cell Biochem; 2010 Dec; 111(5):1231-43. PubMed ID: 20717923
[TBL] [Abstract][Full Text] [Related]
18. The role of FGF-2 and BMP-2 in regulation of gene induction, cell proliferation and mineralization.
Hughes-Fulford M; Li CF
J Orthop Surg Res; 2011 Feb; 6():8. PubMed ID: 21306641
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CIN85-mediated invasion by a novel SH3 domain binding motif in the lysyl oxidase propeptide.
Sato S; Zhao Y; Imai M; Simister PC; Feller SM; Trackman PC; Kirsch KH; Sonenshein GE
PLoS One; 2013; 8(10):e77288. PubMed ID: 24167568
[TBL] [Abstract][Full Text] [Related]
20. FGF and ERK signaling coordinately regulate mineralization-related genes and play essential roles in osteocyte differentiation.
Kyono A; Avishai N; Ouyang Z; Landreth GE; Murakami S
J Bone Miner Metab; 2012 Jan; 30(1):19-30. PubMed ID: 21678127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
